Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats.

O'Shea M, Singh ME, McGregor IS, Mallet PE.

J Psychopharmacol. 2004 Dec;18(4):502-8.

PMID:
15582916
2.
3.
4.

Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison.

Renard J, Krebs MO, Jay TM, Le Pen G.

Psychopharmacology (Berl). 2013 Feb;225(4):781-90. doi: 10.1007/s00213-012-2865-z. Epub 2012 Sep 16.

PMID:
22983145
5.

Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour.

Llorente-Berzal A, Fuentes S, Gagliano H, López-Gallardo M, Armario A, Viveros MP, Nadal R.

Addict Biol. 2011 Oct;16(4):624-37. doi: 10.1111/j.1369-1600.2011.00318.x. Epub 2011 Apr 26.

PMID:
21521421
7.

Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test.

Genn RF, Tucci S, Marco EM, Viveros MP, File SE.

Pharmacol Biochem Behav. 2004 Mar;77(3):567-73.

PMID:
15006468
8.
9.

Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.

Werling LL, Reed SC, Wade D, Izenwasser S.

Int J Dev Neurosci. 2009 May;27(3):263-9. doi: 10.1016/j.ijdevneu.2008.12.008. Epub 2009 Jan 10.

10.
11.

Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors.

Mateos B, Borcel E, Loriga R, Luesu W, Bini V, Llorente R, Castelli MP, Viveros MP.

J Psychopharmacol. 2011 Dec;25(12):1676-90. doi: 10.1177/0269881110370503. Epub 2010 Jun 18.

PMID:
20562169
12.

Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory.

Higuera-Matas A, Botreau F, Miguéns M, Del Olmo N, Borcel E, Pérez-Alvarez L, García-Lecumberri C, Ambrosio E.

Pharmacol Biochem Behav. 2009 Oct;93(4):482-90. doi: 10.1016/j.pbb.2009.06.013. Epub 2009 Jul 2.

PMID:
19576923
13.

Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?

Genn RF, Tucci S, Parikh S, File SE.

Psychopharmacology (Berl). 2004 Dec;177(1-2):93-9. Epub 2004 Jun 16.

PMID:
15205871
15.

Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats.

Marco EM, Pérez-Alvarez L, Borcel E, Rubio M, Guaza C, Ambrosio E, File SE, Viveros MP.

Behav Pharmacol. 2004 Feb;15(1):21-7.

PMID:
15075623
16.

Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety.

Arnold JC, Dielenberg RA, McGregor IS.

Life Sci. 2010 Oct 23;87(17-18):572-8. doi: 10.1016/j.lfs.2010.09.018. Epub 2010 Sep 25.

PMID:
20875432
17.

Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.

Kevin RC, Wood KE, Stuart J, Mitchell AJ, Moir M, Banister SD, Kassiou M, McGregor IS.

J Psychopharmacol. 2017 Jun;31(6):757-769. doi: 10.1177/0269881116684336. Epub 2017 Jan 16.

PMID:
28093016
18.
19.

Behavioral effects of D3 receptor inhibition and 5-HT4 receptor activation on animals undergoing chronic cannabinoid exposure during adolescence.

Abboussi O, Said N, Fifel K, Lakehayli S, Tazi A, El Ganouni S.

Metab Brain Dis. 2016 Apr;31(2):321-7. doi: 10.1007/s11011-015-9753-2. Epub 2015 Oct 26.

PMID:
26497809
20.

Cannabinoid modulation of rat pup ultrasonic vocalizations.

McGregor IS, Dastur FN, McLellan RA, Brown RE.

Eur J Pharmacol. 1996 Oct 10;313(1-2):43-9.

PMID:
8905327

Supplemental Content

Support Center